Phase 1b Portion of the ACTION-1 Phase 1b/3 Trial of RYZ101 in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Progressing after 177 Lu Somatostatin Analogue (SSA) Therapy: Safety and Efficacy Findings.
Journal of Clinical Oncology（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined